Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer
Clinical trial NCT06197438 · UNKNOWN
Trial details
- NCT number
- NCT06197438
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2024-04-11
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.